![Robert Clark](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Clark
Direktor/Vorstandsmitglied bei
INCANNEX HEALTHCARE INC.
Vermögen: 8 375 $ am 31.05.2026
Profil
Robert Bruce Clark currently works at Incannex Healthcare, Inc., as Independent Non-Executive Director from 2023 and Novo Nordisk, Inc., as Vice President-US Regulatory Affairs from 2012.
Mr. Clark also formerly worked at Incannex Healthcare Pty Ltd., as Director from 2022 to 2023 and Pfizer Inc., as VP-Worldwide Regulatory Strategy from 1992 to 2021.
Mr. Clark received his graduate degree from New York Medical College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.11.2025 | 2’500 ( 0.02% ) | 8 375 $ | 31.05.2026 |
Aktive Positionen von Robert Clark
| Unternehmen | Position | Beginn |
|---|---|---|
| INCANNEX HEALTHCARE INC. | Direktor/Vorstandsmitglied | 01.11.2023 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | General Counsel | 01.01.2012 |
Ehemalige bekannte Positionen von Robert Clark
| Unternehmen | Position | Ende |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 01.01.2021 |
Ausbildung von Robert Clark
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
85
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Incannex Healthcare, Inc.
 Incannex Healthcare, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops cannabinoid and psychedelic compound medicines | Health Technology |
New York Medical College
 New York Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
